Language:

Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial

European journal of medical research, 2021-02, Vol.26 (1), p.20-20, Article 20 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2047-783X ;ISSN: 0949-2321 ;EISSN: 2047-783X ;DOI: 10.1186/s40001-021-00490-1 ;PMID: 33573699

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial
Author: JamaliMoghadamSiahkali, Saeidreza ; Zarezade, Besharat ; Koolaji, Sogol ; SeyedAlinaghi, SeyedAhmad ; Zendehdel, Abolfazl ; Tabarestani, Mohammad ; Sekhavati Moghadam, Ehsan ; Abbasian, Ladan ; Dehghan Manshadi, Seyed Ali ; Salehi, Mohamadreza ; Hasannezhad, Malihe ; Ghaderkhani, Sara ; Meidani, Mohsen ; Salahshour, Faeze ; Jafari, Fatemeh ; Manafi, Navid ; Ghiasvand, Fereshteh
Subjects: 2019-nCoV ; Antiviral Agents - administration & dosage ; Antiviral Agents - therapeutic use ; Ascorbic Acid - administration & dosage ; Ascorbic Acid - therapeutic use ; Body Temperature ; Clinical trials ; Coronaviruses ; COVID-19 ; COVID-19 - drug therapy ; Dosage and administration ; Female ; Health aspects ; Humans ; Hydroxychloroquine ; Hydroxychloroquine - therapeutic use ; Immunotherapy ; Infection ; Intensive Care Units ; Laboratories ; Length of Stay ; Lopinavir - therapeutic use ; Male ; Middle Aged ; Mortality ; Oxygen - blood ; Pneumonia ; Respiratory Distress Syndrome - drug therapy ; Respiratory Distress Syndrome - virology ; Ritonavir - therapeutic use ; SARS-COV-2 ; Treatment Outcome ; Variance analysis ; Vitamin C
Is Part Of: European journal of medical research, 2021-02, Vol.26 (1), p.20-20, Article 20
Description: Vitamin C is an essential water-soluble nutrient that functions as a key antioxidant and has been proven to be effective for boosting immunity. In this study, we aimed to assess the efficacy of adding high-dose intravenous vitamin C (HDIVC) to the regimens for patients with severe COVID-19 disease. An open-label, randomized, and controlled trial was conducted on patients with severe COVID-19 infection. The case and control treatment groups each consisted of 30 patients. The control group received lopinavir/ritonavir and hydroxychloroquine and the case group received HDIVC (6 g daily) added to the same regimen. There were no statistically significant differences between two groups with respect to age and gender, laboratory results, and underlying diseases. The mean body temperature was significantly lower in the case group on the 3rd day of hospitalization (p = 0.001). Peripheral capillary oxygen saturations (SpO ) measured at the 3rd day of hospitalization was also higher in the case group receiving HDIVC (p = 0.014). The median length of hospitalization in the case group was significantly longer than the control group (8.5 days vs. 6.5 days) (p = 0.028). There was no significant difference in SpO levels at discharge time, the length of intensive care unit (ICU) stay, and mortality between the two groups. We did not find significantly better outcomes in the group who were treated with HDIVC in addition to the main treatment regimen at discharge. Trial registration irct.ir (IRCT20200411047025N1), April 14, 2020.
Publisher: England: BioMed Central Ltd
Language: English
Identifier: ISSN: 2047-783X
ISSN: 0949-2321
EISSN: 2047-783X
DOI: 10.1186/s40001-021-00490-1
PMID: 33573699
Source: Open Access: DOAJ Directory of Open Access Journals
Open Access: PubMed Central
SpringerOpen
AUTh Library subscriptions: ProQuest Central
MEDLINE
Coronavirus Research Database

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial

Searching Remote Databases, Please Wait